P-268 Myelodysplastic syndromes. Incidence and survival in Republic of Armenia
β Scribed by Daghbashyan, S.; Sahakyan, L.; Kabasakalyan, E.
- Book ID
- 122096009
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 69 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Myelodysplastic syndromes (MDS) became reportable to the Surveillance, Epidemiology, and End Results (SEER) Program (the United States cancer surveillance program) in 2001. This provided the first opportunity to examine the incidence and survival of patients with MDS in
## Abstract Thrombocytopenia and platelet dysfunction contribute to hemorrhagic complications in the myelodysplastic syndromes (MDS). Reliable data regarding the frequency and consequences of thrombocytopenia in MDS are lacking. An extensive literature review indicated that the prevalence of thromb